• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.79% Nasdaq Up 0.16%

    Janus Global Life Sciences T (JAGLX)

    55.11 Up 0.14(0.25%) Jan 23
    Prev Close:54.97
    YTD Return*:34.83%
    Net Assets*:3.28B
    Yield*:N/A

    * As of 31-Dec-14

    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    • No Headlines available for JAGLX at this time.

    Top Holdings

    Symbol% AssetsYTD Return %
    GILD3.360.69
    VRX.TO2.680.94
    CELG2.571.48
    MNK2.56-2.09
    JNJ2.52-0.05

    Fund Basics

    Morningstar Overall Rating:
    Total Assets:3.28B
    Category:Health
    Annual Report Expense Ratio (net):0.92%

    Performance & Risk

    YTD Return:34.83%
    5y Avg Return:24.85%
    Rank in Category (ytd):6
    % Rank in Category (ytd):4.76%
    Beta (3y):0.68
    Morningstar Risk Rating:3

    Fund Summary

    The investment seeks long-term growth of capital. The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets in securities of companies that the portfolio manager believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback